日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient

功能性同源重组 (HR) 筛选表明,大多数 BRCA1/2 突变型乳腺癌和卵巢癌细胞系均具有 HR 功能

Titia G Meijer, John W M Martens, Wendy J C Prager-van der Smissen, Nicole S Verkaik, Corine M Beaufort, Stanley van Herk, Teresa Robert-Finestra, Remco M Hoogenboezem, Kirsten Ruigrok-Ritstier, Maarten W Paul, Joost Gribnau, Eric M J Bindels, Roland Kanaar, Agnes Jager, Dik C van Gent, Antoinette H

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients

概念验证研究:将体外敏感性测试与乳腺癌患者新辅助蒽环类化疗反应联系起来

Ladan, Marjolijn M; Meijer, Titia G; Verkaik, Nicole S; de Monye, Cecile; Koppert, Linetta B; Oomen-de Hoop, Esther; van Deurzen, Carolien H M; Kanaar, Roland; Nonnekens, Julie; van Gent, Dik C; Jager, Agnes

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer

乳腺癌功能性体外组织化疗敏感性测试

Marjolijn M Ladan, Titia G Meijer, Nicole S Verkaik, Zofia M Komar, Carolien H M van Deurzen, Michael A den Bakker, Roland Kanaar, Dik C van Gent, Agnes Jager

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response

前列腺肿瘤组织的体外治疗重现了体内治疗反应

Wenhao Zhang, Wytske M van Weerden, Corrina M A de Ridder, Sigrun Erkens-Schulze, Edgar Schönfeld, Titia G Meijer, Roland Kanaar, Dik C van Gent, Julie Nonnekens

Ex vivo tumor culture systems for functional drug testing and therapy response prediction

用于药物功能测试和治疗反应预测的体外肿瘤培养系统

Meijer, Titia G; Naipal, Kishan At; Jager, Agnes; van Gent, Dik C